Development of a Novel Targeted NGS Panel for Analysis of DNA Methylation Biomarkers in Lung Cancer Research

The webinar will be broadcast 3 times, so please select the one that works best for you.

Europe: October 11, 2023 14:00 BST | 15:00 CEST | 17:00 GST

North America: October 11, 2023 10:00 a.m. PT | 12:00 p.m. CT | 1:00 p.m. ET

Asia Pacific: October 12, 2023 9:30 a.m. IST | 12:00 p.m. SGT | 3:00 p.m. AEDT

Epigenetic modifications such as DNA methylation have long shown promise as potential biomarkers to diagnose and guide treatment of many human diseases, including multiple types of cancers. However, DNA methylation biomarkers have not yet been widely adopted in clinical settings due to some technical limitations of previous analysis methods. This webinar describes the design, development, and testing of a novel panel for targeted NGS analysis of DNA methylation biomarkers implicated in several areas of clinical research, including lung cancer research. The presentation will also cover consulting services available to accelerate the analytical validation of targeted NGS workflows in clinical research laboratories.

Learning objectives:

• Get an overview of the role of DNA methylation in human diseases, including cancer
• Understand the value of analyzing DNA methylation biomarkers to advance cancer research
• Learn how to design, develop, and evaluate performance of targeted NGS panels to study DNA methylation biomarkers in lung cancer research and other clinical research applications